TickerFactsScreenerDevelopers

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2006: $1.33B2007: $1.49B2008: $1.85B2009: $2.00B2010: $1.25B2011: $1.10B2012: $2.88B2013: $1.04B2017: $963.00M2018: $1.78B2019: $1.98B2020: $2.18B2021: $2.17B2022: $2.80B2023: $3.23B2024: $3.30B2025: $3.56B$3.56B
2006Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$3.56B+7.8%
2024$3.30B+2.3%
2023$3.23B+15.2%
2022$2.80B+29.4%
2021$2.17B-0.6%
2020$2.18B+10.2%
2019$1.98B+10.8%
2018$1.78B+85.0%
2017$963.00M—
2013$1.04B-63.9%
2012$2.88B+162.7%
2011$1.10B-12.2%
2010$1.25B-37.4%
2009$2.00B+7.6%
2008$1.85B+24.6%
2007$1.49B+11.7%
2006$1.33B—